National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 15 of 1997)

Overview

The National Health Act 1953 was enacted to establish and maintain a system of national health services and pharmaceutical benefits in Australia. The Act was introduced to address the need for a structured and comprehensive approach to healthcare services and pharmaceutical benefits, ensuring that essential health services and medications are accessible to the population. The policy objective of the Act is to provide a framework that facilitates the equitable distribution of health resources and the regulation of pharmaceutical products to safeguard public health. The Act was enacted by the Parliament of Australia and continues to be an essential piece of legislation underpinning the country's healthcare system. The legislative instrument, No. PB 15 of 1997, specifies a Declaration under subsection 85(2AA) of the Act, which, effective from 1 November 1997, removed certain drugs and medicinal preparations from the scope of Part VII of the National Health Act 1953.

Scope and Application

The National Health Act 1953, as amended by the Declaration under Subsection 85 (2AA) No. PB 15 of 1997, specifies the cessation of certain drugs and medicinal preparations from the scope of Part VII of the Act. This cessation applies to the substances listed in the Schedule, which includes various pharmaceutical compounds and preparations. The Declaration, made by David Trevor Graham, the Assistant Secretary of the Pharmaceutical Benefits Branch and Delegate of the Minister for Health and Family Services, follows advice from the Pharmaceutical Benefits Advisory Committee. The cessation applies nationally across the Commonwealth of Australia and impacts all entities and persons involved in the supply, prescription, or distribution of the specified substances under the Pharmaceutical Benefits Scheme. It is pertinent to note that this legislative instrument excludes any other drugs or medicinal preparations not listed in the Schedule, thereby maintaining the applicability of the Act to other substances not affected by this specific Declaration. The implementation of this legislative instrument is comprehensive and enforceable throughout Australia, ensuring that the changes are uniformly applied across all states and territories.

Key Provisions

The main operative sections of this Declaration under subsection 85(2AA) of the National Health Act 1953 (section 85(2AA)) pertain to the cessation of certain drugs and medicinal preparations from being subject to Part VII of the Act. Specifically, section 2 of the Declaration states that the drugs and medicinal preparations listed in the Schedule will no longer be covered by Part VII of the National Health Act 1953. This means that these particular substances will no longer be eligible for benefits under the Pharmaceutical Benefits Scheme (PBS) as of the commencement date, 1 November 1997. The obligations and requirements imposed by this Act primarily involve the cessation of the listed drugs and preparations from being covered under the PBS. This legislative action requires the Department of Health and Family Services, through its Pharmaceutical Benefits Branch, to ensure that these substances are no longer listed or reimbursed under the PBS. The declaration process, as outlined in section 85(2AA) of the Act, mandates that the Assistant Secretary, Pharmaceutical Benefits Branch, obtains advice from the Pharmaceutical Benefits Advisory Committee before making such a declaration. This ensures that the decision to remove these drugs from the PBS is informed by expert advice and takes into account relevant health and economic factors. In terms of legal consequences, breaches of the provisions in this Declaration could result in civil or criminal penalties, although specific offences and penalties are not detailed within the text of the Declaration itself. Generally, under Australian law, non-compliance with provisions of the National Health Act 1953 may result in penalties such as fines or imprisonment, depending on the nature and severity of the breach. The maximum penalties would be determined by the specific sections of the Act that are contravened, but they could potentially include substantial fines and imprisonment terms for more serious offences. The precise penalties would be outlined in the relevant sections of the National Health Act 1953 and any subsidiary legislation.